223 related articles for article (PubMed ID: 34497233)
21. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
[TBL] [Abstract][Full Text] [Related]
22. T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
Kawakami F; Kawakami T; Yamane T; Maruyama M; Kobayashi J; Nishina S; Sakai H; Higuchi Y; Hamanaka K; Hirokawa M; Nakao S; Nakazawa H; Ishida F
Int J Hematol; 2022 Jun; 115(6):816-825. PubMed ID: 35275353
[TBL] [Abstract][Full Text] [Related]
23. The clinical characteristics and therapy response of patients with acquired pure red cell aplasia.
Fu R; Zhang T; Liu B; Song J; Wang G; Li L; Wang H; Xing L; Wu Y; Guan J; Shao Z
Hematology; 2018 Oct; 23(9):639-645. PubMed ID: 29754581
[TBL] [Abstract][Full Text] [Related]
24. Somatic mutations in acquired pure red cell aplasia.
Kawakami T; Nakazawa H; Ishida F
Semin Hematol; 2022 Jul; 59(3):131-136. PubMed ID: 36115689
[TBL] [Abstract][Full Text] [Related]
25. Gene mutation profile in patients with acquired pure red cell aplasia.
Long Z; Li H; Du Y; Chen M; Zhuang J; Han B
Ann Hematol; 2020 Aug; 99(8):1749-1754. PubMed ID: 32594217
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study.
Chen Z; Chen M; Yang C; Han B
Ann Hematol; 2020 Jul; 99(7):1485-1491. PubMed ID: 32488602
[TBL] [Abstract][Full Text] [Related]
27. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
[TBL] [Abstract][Full Text] [Related]
28. [Aplastic anemia and pure red cell aplasia].
Sawada K; Hirokawa M
Nihon Rinsho; 2008 Mar; 66(3):505-11. PubMed ID: 18326319
[TBL] [Abstract][Full Text] [Related]
29. Acquired pure red cell aplasia in Japan.
Mamiya S; Itoh T; Miura AB
Eur J Haematol; 1997 Oct; 59(4):199-205. PubMed ID: 9338617
[TBL] [Abstract][Full Text] [Related]
30. Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment.
Vo AK; Kollsete Gjelberg H; Hovland R; Lindstad Brattås MK; Bruserud Ø; Reikvam H
Case Rep Hematol; 2020; 2020():1262038. PubMed ID: 32082654
[TBL] [Abstract][Full Text] [Related]
31. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Hirokawa M; Sawada K; Fujishima N; Kawano F; Kimura A; Watanabe T; Arai A; Matsui T; Nakao S; Urabe A; Omine M; Ozawa K
Am J Hematol; 2009 Mar; 84(3):144-8. PubMed ID: 19195037
[TBL] [Abstract][Full Text] [Related]
32. DNA Methyl Transferase 3A (DNMT3A) Mutation Presenting as Isolated Pure Red Cell Aplasia.
Sidda A; Manu G; Alsharedi M; Dotson J; Nahar N
J Investig Med High Impact Case Rep; 2022; 10():23247096221097523. PubMed ID: 35593442
[TBL] [Abstract][Full Text] [Related]
33. The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann syndrome.
Ebihara Y; Manabe A; Tsuruta T; Ishikawa K; Hasegawa D; Ohtsuka Y; Kawasaki H; Ogami K; Wada Y; Kanda T; Tsuji K
Int J Hematol; 2007 Dec; 86(5):446-50. PubMed ID: 18192114
[TBL] [Abstract][Full Text] [Related]
34. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation.
Simkins A; Maiti A; Short NJ; Jain N; Popat U; Patel KP; Oo TH
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):115-118. PubMed ID: 29409729
[TBL] [Abstract][Full Text] [Related]
35. Pure Red Cell Aplasia Encountered in a Tertiary Care Hematology Laboratory: A Series of Nine Distinctive Cases.
Kala M; Das K; Baveja A; Raturi M; Dhebane M; Ahmad S; Mehrotra M
J Lab Physicians; 2023 Jun; 15(2):316-320. PubMed ID: 37323590
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Zhu KE; Li JP; Zhang T; Zhong J; Chen J
Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Carson KR; Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
[TBL] [Abstract][Full Text] [Related]
38. Clinical value of bone marrow cultures in childhood pure red cell aplasia.
Gussetis ES; Peristeri J; Kitra V; Liakopoulou T; Kattamis A; Graphakos S
J Pediatr Hematol Oncol; 1998; 20(2):120-4. PubMed ID: 9544161
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
